Skip to main content
Onconic Therapeutics Inc. logo

Onconic Therapeutics Inc. — Investor Relations & Filings

Ticker · 476060 ISIN · KR7476060009 KO Manufacturing
Open in API
Filings indexed 125 across all filing types
Latest filing 2024-11-22 Capital/Financing Update
Country KR South Korea
Listing KO 476060

About Onconic Therapeutics Inc.

http://onconic.co.kr/

Onconic Therapeutics Inc., established in 2020, is a biopharmaceutical company specializing in the research and development of innovative drugs. A subsidiary of Jeil Pharmaceutical, the company focuses on creating novel treatments for cancer and gastrointestinal disorders, including gastroesophageal reflux disease. Its development strategy prioritizes therapeutics for conditions with high unmet medical needs and significant market potential. Onconic Therapeutics actively advances its pipeline of drug candidates through various stages of clinical trials.

Recent filings

Filing Released Lang Actions
[기재정정]증권신고서(지분증권)
Capital/Financing Update Classification · 95% confidence The document is a '증권신고서(지분증권) 정정신고' (Securities Registration Statement Amendment) for Onconic Therapeutics. It details corrections to specific sections of a previously filed securities registration statement, including investment risk factors and market competition analysis. In the context of financial filings, a Securities Registration Statement (and its amendments) is classified as a regulatory filing related to capital raising or public offering, which falls under the 'Regulatory Filings' (RNS) category as it does not fit into the specific categories like 10-K or ER.
2024-11-22 Korean
[기재정정]증권신고서(지분증권)
Capital/Financing Update Classification · 95% confidence The document is a 'Securities Registration Statement' (증권신고서) amendment (정정신고서) filed by Onconic Therapeutics. It details changes to the initial registration statement, including updates to the offering schedule, demand forecasting dates, and risk factors. This is a formal regulatory filing related to an IPO or capital issuance process, which falls under the 'Regulatory Filings' category as it is a specific legal document required by financial regulators (FSS) for public offerings.
2024-11-08 Korean
[첨부추가]증권신고서(지분증권)
Share Issue/Capital Change Classification · 95% confidence The document is a '증권신고서' (Securities Registration Statement) filed with the Financial Services Commission (FSC) of South Korea. It contains detailed information about the company (Onconic Therapeutics), the securities being offered, investment risks, and business operations. This is a formal regulatory filing required for public offerings or capital raising activities, which falls under the 'Regulatory Filings' category as it is a primary legal document for securities registration.
2024-10-16 Korean
감사보고서 (2023.12)
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report' (감사보고서) for Onconic Therapeutics, covering the fiscal year 2023. It includes the independent auditor's report, financial statements (balance sheet, income statement, statement of changes in equity, cash flow statement), and detailed notes to the financial statements. This is a comprehensive financial document, not an announcement or a summary, and fits the definition of an Audit Report/Information (AR). FY 2023
2024-04-08 Korean
감사보고서 (2022.12)
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report' (감사보고서) for Onconic Therapeutics, covering the fiscal years 2021 and 2022. It includes the independent auditor's report, financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes to the financial statements. This is a comprehensive financial reporting document, not an announcement or a summary, and fits the definition of an Audit Report/Information (AR). FY 2022
2023-03-31 Korean

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.